Making Biospsies More Accurate

Dr. Joseph L. Chin (2003 Research Grant)

Physicians and patients have tough decisions to make when pre-cancerous lesions are found during biopsies because they have the potential to become cancerous and must be either removed or monitored. 

Surgically removing the whole prostate for the sake of a tiny pre-cancerous lesion is not ideal since prostatectomy has side effects and risks. However, pinpointing and monitoring tiny lesions is almost impossible using the standard techniques (needle biopsy guided by two-dimensional ultrasound imaging). 

Dr. Joseph Chin and his team are developing and testing state-of-the-art software that creates three-dimensional ultrasound images during biopsy. The new system will let doctors precisely locate lesions. Because the new software is compatible with current ultrasound machines and biopsy techniques, it will be cost-effective. Patient trials are not far off and the first publication on this experimental technology is in press.

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive